Digital Manufacturing Market

Digital Manufacturing Market for Biologics - Distribution by Type of Technology, Deployment Options, Types of Biologics Manufactured, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    176

  • Pages
    254

  • View Count
    15625

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Digital Manufacturing for Biologics
3.3. Emerging Technologies that Support Digital Manufacturing
3.3.1. Process Analytical Technology (PAT)
3.3.2. Data Analysis Software (DAS)
3.3.3. Bioprocess Digital Twin
3.3.4. Manufacturing Execution System (MES)
3.4. Challenges Associated with the Adoption of Digital Manufacturing of Biologics
3.5. Future Perspectives

4. MARKERT LANDSCAPE
4.1. Chapter Overview
4.2. List of Process Analytical Technology (PAT) Companies
4.2.1. Analysis by Year of Establishment 
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters (Region-wise)
4.2.4. Analysis by Location of Headquarters (Country-wise)
4.2.5. Analysis by Type of Company
4.2.6. Analysis by Number of Platforms Offered
4.2.7. Analysis by Deployment Options 
4.2.8. Analysis by Platform Capabilities

4.2.9. Analysis by Type(s) of Biologic(s) Manufactured
4.2.10. Analysis by Other Compatible Platforms
4.2.11. Analysis by Type of End User(s)
4.2.12. Analysis by Year of Establishment, Location of Headquarters and Platform Capabilities
4.2.13. Analysis by Years of Experience, Location of Headquarters and Number of Platform Capabilities (Dot-Plot Representation)

4.3. List of Data Analysis Software (DAS) Companies
4.3.1. Analysis by Year of Establishment 
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters (Region-wise)
4.3.4. Analysis by Location of Headquarters (Country-wise)
4.3.5. Analysis by Type of Company
4.3.6. Analysis by Number of Software Offered
4.3.7. Analysis by Deployment Options 
4.3.8. Analysis by Software Capabilities
4.3.9. Analysis by Other Compatible Platforms
4.3.10. Analysis by Type of End User(s)
4.3.11. Analysis by Year of Establishment, Location of Headquarters and Software Capabilities
4.3.12. Analysis by Years of Experience, Location of Headquarters and Number of Software Capabilities (Dot-Plot Representation)

4.4. List of Manufacturing Execution System (MES) Companies
4.4.1. Analysis by Year of Establishment 
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters (Region-wise)
4.4.4. Analysis by Location of Headquarters (Country-wise)
4.4.5. Analysis by Type of Company
4.4.6. Analysis by Number of Platforms Offered
4.4.7. Analysis by Deployment Options 
4.4.8. Analysis by Platform Capabilities
4.4.9. Analysis by Integrating Software
4.4.10. Analysis by Type of Service(s) Offered
4.4.11. Analysis by Analysis by Years of Experience, Location of Headquarters and Number of Platform Capabilities (Dot-Plot Representation)

4.5. List of Digital Twin Companies
4.5.1. Analysis by Year of Establishment 
4.5.2. Analysis by Company Size
4.5.3. Analysis by Location of Headquarters (Region-wise)
4.5.4. Analysis by Location of Headquarters (Country-wise)
4.5.5. Analysis by Number of Platforms Offered
4.5.6. Analysis by Area(s) of Application
4.5.7. Analysis by Type of End User(s)
4.5.8. Analysis by Years of Experience, Location of Headquarters and Area(s) of Application (Dot-Plot Representation)

5. TECHNOLOGY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Technology Competitiveness Analysis: Process Analytical Technologies
5.4.1. Process Analytical Technologies Offered by Small Companies
5.4.2. Process Analytical Technologies Offered by Mid-sized Companies 
5.4.3. Process Analytical Technologies Offered by Large Companies
5.4.4. Process Analytical Technologies Offered by Very Large Companies
5.5. Technology Competitiveness Analysis: Data Analysis Software
5.6. Technology Competitiveness Analysis: Manufacturing Execution System
5.6.1. Manufacturing Execution Systems Offered by Small Companies
5.6.2. Manufacturing Execution Systems Offered by Mid-sized Companies
5.6.3. Manufacturing Execution Systems Offered by Large and Very Large Companies
5.7. Technology Competitiveness Analysis: Digital Twins

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. AspenTech
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Technology Portfolio
6.2.4. Recent Developments and Future Outlook

6.3. FUJIFILM Diosynth Biotechnologies
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Technology Portfolio
6.3.4. Recent Developments and Future Outlook

6.4. Merck
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Technology Portfolio
6.4.4. Recent Developments and Future Outlook

6.5. Thermo Fisher Scientific
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Technology Portfolio
6.5.4. Recent Developments and Future Outlook

6.6. Bioreactors.net
6.6.1. Company Overview
6.6.2. Technology Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. Sartorius
6.7.1. Company Overview
6.7.2. Financial Information
6.7.3. Technology Portfolio
6.7.4. Recent Developments and Future Outlook

6.8. Dassault Systèmes
6.8.1. Company Overview
6.8.2. Financial Information
6.8.3. Area(s) of Application
6.8.4. Recent Developments and Future Outlook

6.9. GE Healthcare
6.9.1. Company Overview
6.9.2. Technology Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Körber
6.10.1. Company Overview
6.10.2. Financial Information
6.10.3. Technology Portfolio
6.10.4. Recent Developments and Future Outlook

7. BENCHMARKING ANALYSIS
7.1. Chapter Overview
7.2. Methodology and Key Assumptions
7.3. Competitive Benchmarking by Company Size and Region
7.3.1. Competitive Benchmarking: Small Players based in North America (Peer Group I)
7.3.2. Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
7.3.3. Competitive Benchmarking: Large and Very Large Players based in North America (Peer Group III)
7.3.4. Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
7.3.5. Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
7.3.6. Competitive Benchmarking: Large and Very Large Players based in Europe (Peer Group VI)
7.3.7. Competitive Benchmarking: Small, Mid-sized and Very Large Players based in Asia-Pacific (Peer Group VII)
7.4. Competitive Benchmarking: Pockets of Innovation and White Spaces

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Digital Biomanufacturing: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnership
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Year and Type of Partnership
8.3.4. Analysis by Type of Technology
8.3.5. Analysis by Year of Partnership and Type of Technology
8.3.6. Most Active Players: Analysis by Number of Partnerships
8.3.7. Analysis by Geography
8.3.7.1. Intracontinental and Intercontinental Agreements
8.3.7.2. International and Local Agreements

9. MARKET CONCENTRATION ANALYSIS
9.1. Chapter Overview
9.2. Assumptions and Key Parameters
9.3. Methodology
9.4. Market Concertation Analysis: Top Digital Biomanufacturing Providers

10. INDUSTRY LIFECYCLE ANALYSIS
10.1. Chapter Overview
10.2. Industry Lifecycle Analysis

10.3. Digital Biomanufacturing: Historical Timeline of Key Events
10.4. Digital Biomanufacturing: Start-up Activity
10.5. Digital Biomanufacturing: Established Players Activity
10.6. Digital Biomanufacturing: Partnership and Collaboration Trends
10.7. Digital Biomanufacturing: Funding and Investments Trends
10.8. Current Barriers to Wider Adoption of Digitalization in Biomanufacturing
10.9. Future Outlook of Digital Biomanufacturing

10.10. Industry Lifecycle Analysis: Digital Biomanufacturing 

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Global Digital Manufacturing Market for Biologics, 2023-2035
11.4. Digital Manufacturing Market for Biologics: Analysis by Type of Technology
11.4.1. Process Analytical Technology Market for Biologic Manufacturing, 2023-2035
11.4.2. Data Analysis Software Market for Biologic Manufacturing, 2023-2035
11.4.3. Manufacturing Execution System Market for Biologic Manufacturing, 2023-2035
11.4.4. Digital Twin Market for Biologic Manufacturing, 2023-2035

11.5. Digital Manufacturing Market for Biologics: Analysis by Type of Deployment Options
11.5.1. Market for Cloud-based Deployment Options, 2023-2035
11.5.2. Market for On-premises Deployment Options, 2023-2035

11.6. Digital Manufacturing Market for Biologics: Analysis by Type(s) of Biologic(s) Manufactured
11.6.1. Market for Antibodies, 2023-2035
11.6.2. Market for Cell and Gene Therapies, 2023-2035
11.6.3. Market for Proteins, 2023-2035
11.6.4. Market for Vaccines, 2023-2035
11.6.5. Market for Others, 2023-2035

11.7. Digital Manufacturing Market for Biologics: Analysis by Geography
11.7.1. Market in North America, 2023-2035
11.7.2. Market in Europe, 2023-2035
11.7.3. Market in Asia-Pacific, 2023-2035
11.7.4. Market in Latin America, 2023-2035
11.7.5. Market in Middle East and North Africa, 2023-2035

12. CONCLUDING REMARKS

13. INTERVIEW TRANSCRIPTS
13.1. Chapter Overview
13.2. BioIntelligence Technologies
13.2.1. Interview Transcript: Joel Sirois, Chief Executive Officer and President

13.3. Yokogawa Insilico Biotechnology
13.3.1. Interview Transcript: Klaus Mauch, Managing Director and Chief Executive Officer

13.4. Aizon
13.4.1 Company Snapshot
13.4.2. Interview Transcript: Tudor Munteanu, Vice President of Operations and Strategic Initiatives

13.5. MasterControl
13.5.1 Company Snapshot
13.5.2. Interview Transcript: Ciaran O'Keeffe, Director, Business Development and Channel Sales, and Isura Sirisena, Quality and Manufacturing Digitization Specialist

13.6. Trunovate
13.6.1 Company Snapshot
13.6.2. Interview Transcript: Yaron Halfon, Director of Sales

13.7. Dassault Systèmes
13.7.1 Company Snapshot
13.7.2. Interview Transcript: Barbara Holtz, Business Consultant

14. APPENDIX I: TABULATED DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Overview of Digital Biomanufacturing in Healthcare
Figure 3.2 Software Capabilities in Digital Biomanufacturing
Figure 3.3 Challenges Associated with the Adoption of Digital Biomanufacturing
Figure 4.1 Digital Biomanufacturing Companies: Distribution by Type of Technology
Figure 4.2 Process Analytical Technology Companies: Distribution by Year of Establishment
Figure 4.3 Process Analytical Technology Companies: Distribution by Company Size
Figure 4.4 Process Analytical Technology Companies: Distribution by Location of Headquarters (Region-wise)
Figure 4.5 Process Analytical Technology Companies: Distribution by Location of Headquarters (Country-wise)
Figure 4.6 Process Analytical Technology Companies: Distribution by Type of Company
Figure 4.7 Process Analytical Technology Companies: Distribution by Number of Platforms Offered
Figure 4.8 Process Analytical Technology Companies: Distribution by Deployment Options
Figure 4.9 Process Analytical Technologies: Distribution by Platform Capabilities
Figure 4.10 Process Analytical Technologies: Distribution by Type(s) of Biologic(s) Manufactured
Figure 4.11 Process Analytical Technologies: Distribution by Other Compatible Platforms
Figure 4.12 Process Analytical Technology Providers: Distribution by Type of End User(s)
Figure 4.13 Process Analytical Technologies: Distribution by Year of Establishment, Location of Headquarters and Platform Capabilities
Figure 4.14 Process Analytical Technologies offered by Small Companies: Distribution by Years of Experience, Location of Headquarters and Number of Platform Capabilities
Figure 4.15 Process Analytical Technologies offered by Mid-sized Companies: Distribution by Years of Experience, Location of Headquarters and Number of Platform Capabilities
Figure 4.16 Process Analytical Technologies offered by Large Companies: Distribution by Years of Experience, Location of Headquarters and Number of Platform Capabilities
Figure 4.17 Process Analytical Technologies offered by Very Large Companies: Distribution by Years of Experience, Location of Headquarters and Number of Platform Capabilities
Figure 4.18 Data Analysis Software Companies: Distribution by Year of Establishment
Figure 4.19 Data Analysis Software Companies: Distribution by Company Size
Figure 4.20 Data Analysis Software Companies: Distribution by Location of Headquarters (Region-wise)
Figure 4.21 Data Analysis Software Companies: Distribution by Location of Headquarters (Country-wise)
Figure 4.22 Data Analysis Software Companies: Distribution by Type of Company
Figure 4.23 Data Analysis Software Companies: Distribution by Number of Software Offered
Figure 4.24 Data Analysis Software Companies: Distribution by Deployment Options
Figure 4.25 Data Analysis Software: Distribution by Software Capabilities
Figure 4.26 Data Analysis Software: Distribution by Other Compatible Platforms
Figure 4.27 Data Analysis Providers: Distribution by Type of End User(s)
Figure 4.28 Data Analysis Software: Distribution by Year of Establishment, Location of Headquarters and Software Capabilities
Figure 4.29 Data Analysis Software Providers: Distribution by Years of Experience, Location of Headquarters and Number of Software Capabilities
Figure 4.30 Manufacturing Execution System Companies: Distribution by Year of Establishment
Figure 4.31 Manufacturing Execution System Companies: Distribution by Company Size
Figure 4.32 Manufacturing Execution System Companies: Distribution by Location of Headquarters (Region-wise)
Figure 4.33 Manufacturing Execution System Companies: Distribution by Location of Headquarters (Country-wise)
Figure 4.34 Manufacturing Execution System Companies: Distribution by Type of Company
Figure 4.35 Manufacturing Execution System Companies: Distribution by Number of Platforms Offered
Figure 4.36 Manufacturing Execution System Companies: Distribution by Deployment Options
Figure 4.37 Manufacturing Execution Systems: Distribution by Platform Capabilities
Figure 4.38 Manufacturing Execution Systems: Distribution by Integrating Software
Figure 4.39 Manufacturing Execution Systems: Distribution by Types of Service(s) Offered
Figure 4.40 Manufacturing Execution Systems Offered by Small Companies: Distribution by Years of Experience, Location of Headquarters and Number of Platform Capabilities
Figure 4.41 Manufacturing Execution Systems Offered by Mid-sized Companies: Distribution by Years of Experience, Location of Headquarters and Number of Platform Capabilities
Figure 4.42 Manufacturing Execution Systems offered by Large and Very Large Companies: Distribution by Years of Experience, Location of Headquarters and Number of Platform Capabilities
Figure 4.43 Digital Twin Companies: Distribution by Year of Establishment
Figure 4.44 Digital Twin Companies: Distribution by Company Size
Figure 4.45 Digital Twin Companies: Distribution by Location of Headquarters (Region-wise)
Figure 4.46 Digital Twin Companies: Distribution by Location of Headquarters (Country-wise)
Figure 4.47 Digital Twin Companies: Distribution by Number of Platforms Offered
Figure 4.48 Digital Twin Technologies: Distribution by Area(s) of Application
Figure 4.49 Digital Twin Companies: Distribution by Type of End User(s)
Figure 4.50 Digital Twin Companies: Distribution by Years of Experience, Location of Headquarters and Area(s) of Application
Figure 5.1 Process Analytical Technologies Offered by Small Companies
Figure 5.2 Process Analytical Technologies Offered by Mid-sized Companies
Figure 5.3 Process Analytical Technologies Offered by Large Companies
Figure 5.4 Process Analytical Technologies Offered by Very Large Companies
Figure 5.5 Technology Competitiveness Analysis: Data Analysis Software
Figure 5.6 Manufacturing Execution Systems Offered by Small Companies
Figure 5.7 Manufacturing Execution Systems Offered by Mid-sized Companies
Figure 5.8 Manufacturing Execution Systems Offered by Large and Very Large Companies
Figure 5.9 Technology Competitiveness Analysis: Digital Twins Technologies
Figure 6.1 AspenTech: Annual Revenues, FY 2020-3M 2023 (USD Million)
Figure 6.2 AspenTech: Technology Capabilities
Figure 6.3 FUJIFILM Diosynth Biotechnologies: Annual Revenues, FY 2018-H1 2022  (USD Million)
Figure 6.4 FUJIFILM Diosynth Biotechnologies: Technology Capabilities
Figure 6.5 Merck: Annual Revenues, FY 2018-9M 2022 (USD Billion)
Figure 6.6 Merck: Technology Capabilities
Figure 6.7 Thermo Fisher Scientific: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Figure 6.8 Thermo Fisher Scientific: Technology Capabilities
Figure 6.9 Bioreactors.net: Technology Capabilities
Figure 6.10 Sartorius: Annual Revenues, FY 2017-FY 2022 (USD Million)
Figure 6.11 Sartorius: Technology Capabilities
Figure 6.12 Dassault Systèmes: Annual Revenues, FY 2017-FY 2021 (USD Billion)
Figure 6.13 Dassault Systèmes: Area(s) of Application(s)
Figure 6.14 GE Healthcare: Technology Capabilities
Figure 6.15 Körber: Annual Revenues, FY 2019-FY 2021 (USD Million)
Figure 6.16 Körber: Technology Capabilities
Figure 7.1 Benchmark Analysis: Distribution by Company Size and Region 
Figure 7.2 Competitive Benchmarking: Small Players based in North America (Peer Group I)
Figure 7.3 Competitive Benchmarking: Mid-sized Players based in North America (Peer Group II)
Figure 7.4 Competitive Benchmarking: Large and Very Large Players based in North America (Peer Group III)
Figure 7.5 Competitive Benchmarking: Small Players based in Europe (Peer Group IV)
Figure 7.6 Competitive Benchmarking: Mid-sized Players based in Europe (Peer Group V)
Figure 7.7 Competitive Benchmarking: Large and Very Large Players based in Europe (Peer Group VI)
Figure 7.8 Competitive Benchmarking: Small, Mid-sized, Large and Very Large Players based in Asia-Pacific (Peer Group VII)
Figure 7.9 White Spaces: Distribution of Peer Groups by Type of Technology and Type of Company
Figure 8.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Technology
Figure 8.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Technology
Figure 8.6 Most Active Players: Distribution by Number of Partnerships
Figure 8.7 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 8.8 Partnerships and Collaborations: International and Local Agreements
Figure 9.1 Market Concertation Analysis: Comparison of Key Offerings of Top Digital Biomanufacturing Providers
Figure 10.1 Digital Biomanufacturing: Historical Timeline of Key Events
Figure 10.2 Digital Biomanufacturing: Start-up Activity
Figure 10.3 Digital Biomanufacturing: Established Players Activity
Figure 10.4 Digital Biomanufacturing: Partnership and Collaboration Trends
Figure 10.5 Digital Biomanufacturing: Funding and Investments Trends
Figure 10.6 Current Barriers to Wider Adoption of Digitalization in Biomanufacturing
Figure 10.7 Future Outlook of Digital Biomanufacturing
Figure 10.8 Industry Lifecycle Analysis: Digital Biomanufacturing
Figure 11.1 Global Digital Manufacturing Market for Biologics, 2023-2035 (USD Million)
Figure 11.2 Digital Manufacturing Market for Biologics: Distribution by Type of Technology, 2023 and 2035
Figure 11.3 Process Analytical Technology Market for Biologic Manufacturing, 2023-2035 (USD Million)
Figure 11.4 Data Analysis Software Market for Biologic Manufacturing, 2023-2035 (USD Million)
Figure 11.5 Manufacturing Execution System Market for Biologic Manufacturing, 2023-2035 (USD Million)
Figure 11.6 Digital Twin Market for Biologic Manufacturing, 2023-2035 (USD Million)
Figure 11.7 Digital Manufacturing Market for Biologics: Distribution by Type of Deployment Options, 2023 and 2035
Figure 11.8 Digital Biomanufacturing Market for Cloud-based Deployment Options, 2023-2035 (USD Million)
Figure 11.9 Digital Biomanufacturing Market for On-premises Deployment Options, 2023-2035 (USD Million)
Figure 11.10 Digital Manufacturing Market for Biologics: Distribution by Type(s) of Biologic(s) Manufactured, 2023 and 2035
Figure 11.11 Digital Manufacturing Market for Antibodies, 2023-2035 (USD Million)
Figure 11.12 Digital Manufacturing Market for Cell and Gene Therapies, 2023-2035 (USD Million)
Figure 11.13 Digital Manufacturing Market for Proteins, 2023-2035 (USD Million)
Figure 11.14 Digital Manufacturing Market for Vaccines, 2023-2035 (USD Million)
Figure 11.15 Digital Manufacturing Market for Others, 2023-2035 (USD Million)
Figure 11.16 Digital Manufacturing Market for Biologics: Distribution by Geography, 2023 and 2035
Figure 11.17 Digital Biomanufacturing Market in North America, 2023-2035 (USD Million)
Figure 11.18 Digital Biomanufacturing Market in Europe, 2023-2035 (USD Million)
Figure 11.19 Digital Biomanufacturing Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 11.20 Digital Biomanufacturing Market in Latin America, 2023-2035 (USD Million)
Figure 11.21 Digital Biomanufacturing Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.1 Concluding Remarks: Market Overview of Process Analytical Technologies
Figure 12.2 Concluding Remarks: Market Overview of Data Analysis Software
Figure 12.3 Concluding Remarks: Market Overview of Manufacturing Execution Systems
Figure 12.4 Concluding Remarks: Market Overview of Digital Twins
Figure 12.5 Concluding Remarks: Partnerships and Collaborations
Figure 12.6 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 4.1 List of Process Analytical Technology Companies
Table 4.2 Process Analytical Technology Companies: Information on Platform and Deployment Options
Table 4.3 Process Analytical Technologies: Information on Platform Capabilities
Table 4.4 Process Analytical Technologies: Information on Type(s) of Biologic(s) Manufactured, Other Compatible Platforms and Type of End User(s)
Table 4.5 List of Data Analysis Software Companies
Table 4.6 Data Analysis Software Companies: Information on Deployment Options
Table 4.7 Data Analysis Software: Information on Software Capabilities
Table 4.8 Data Analysis Software: Information on Type of Biologic(s) Manufactured, Other Compatible Platforms and Type of End User(s)
Table 4.9 List of Manufacturing Execution System Companies
Table 4.10 Manufacturing Execution System Companies: Information on Deployment Options
Table 4.11 Manufacturing Execution Systems: Information on Platform Capabilities
Table 4.12 Manufacturing Execution Systems: Information on Area(s) of Application and Type of End User(s)
Table 4.13 List of Digital Twin Companies
Table 4.14 Digital Twins Technologies: Information on Area(s) of Application and Type of End User(s)
Table 5.1 Technology Competitiveness Analysis: Information on Peer Groups
Table 6.1  List of Companies Profiled
Table 6.2 AspenTech: Company Snapshot
Table 6.3 AspenTech: Recent Developments and Future Outlook
Table 6.4 FUJIFILM Diosynth Biotechnologies: Company Snapshot
Table 6.5 FUJIFILM Diosynth Biotechnologies: Recent Developments and Future Outlook
Table 6.6 Merck: Company Snapshot
Table 6.7 Merck: Recent Developments and Future Outlook
Table 6.8 Thermo Fisher Scientific: Company Snapshot
Table 6.9 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 6.10 Bioreactors.net: Company Snapshot
Table 6.11 Sartorius: Company Snapshot
Table 6.12 Sartorius: Recent Developments and Future Outlook
Table 6.13 Dassault Systèmes: Company Snapshot
Table 6.14 GE Healthcare: Company Snapshot
Table 6.15 GE Healthcare: Recent Developments and Future Outlook
Table 6.16 Körber: Company Snapshot
Table 6.17 Körber: Recent Developments and Future Outlook
Table 7.1 Benchmark Analysis: Information on Peer Groups
Table 8.1 Digital Biomanufacturing: List of Partnerships and Collaborations, 2018-2022
Table 8.2 Digital Biomanufacturing: Information on Type of Agreement (Country-wise and Continent-wise), 2018-2022
Table 9.1 Market Concertation Analysis: Information on Years of Entrance and Key Offerings of Top Digital Biomanufacturing Providers
Table 10.1 Industry Lifecycle Analysis
Table 10.2 Industry Lifecycle Analysis: Digital Biomanufacturing
Table 13.1 BioIntelligence Technologies: Company Snapshot
Table 13.2 Yokogawa Insilico Biotechnology: Company Snapshot
Table 13.3 MasterControl: Company Snapshot
Table 13.4 Trunovate: Company Snapshot
Table 13.5 Dassault Systèmes: Company Snapshot
Table 14.1 Digital Biomanufacturing Companies: Distribution by Type of Technology
Table 14.2 Process Analytical Technology Companies: Distribution by Year of Establishment
Table 14.3 Process Analytical Technology Companies: Distribution by Company Size
Table 14.4 Process Analytical Technology Companies: Distribution by Location of Headquarters (Region-wise)
Table 14.5 Process Analytical Technology Companies: Distribution by Location of Headquarters (Country-wise)
Table 14.6 Process Analytical Technology Companies: Distribution by Type of Company
Table 14.7 Process Analytical Technology Companies: Distribution by Number of Platforms Offered
Table 14.8 Process Analytical Technology Companies: Distribution by Deployment Options
Table 14.9 Process Analytical Technologies: Distribution by Platform Capabilities
Table 14.10 Process Analytical Technologies: Distribution by Type(s) of Biologic(s) Manufactured
Table 14.11 Process Analytical Technologies: Distribution by Other Compatible Platforms
Table 14.12 Process Analytical Technology Providers: Distribution by Type of End User(s)
Table 14.13 Process Analytical Technologies: Distribution by Year of Establishment, Location of Headquarters and Platform Capabilities
Table 14.14 Data Analysis Software Companies: Distribution by Year of Establishment
Table 14.15 Data Analysis Software Companies: Distribution by Company Size
Table 14.16 Data Analysis Software Companies: Distribution by Location of Headquarters (Region-wise)
Table 14.17 Data Analysis Software Companies: Distribution by Location of Headquarters (Country-wise)
Table 14.18 Data Analysis Software Companies: Distribution by Type of Company
Table 14.19 Data Analysis Software Companies: Distribution by Number of Software Offered
Table 14.20 Data Analysis Software Companies: Distribution by Deployment Options
Table 14.21 Data Analysis Software: Distribution by Software Capabilities
Table 14.22 Data Analysis Software: Distribution by Other Compatible Platforms
Table 14.23 Data Analysis Providers: Distribution by Type of End User(s)
Table 14.24 Data Analysis Software: Distribution by Year of Establishment, Location of Headquarters and Software Capabilities
Table 14.25 Manufacturing Execution System Companies Distribution by Year of Establishment
Table 14.26 Manufacturing Execution System Companies: Distribution by Company Size
Table 14.27 Manufacturing Execution System Companies: Distribution by Location of Headquarters (Region-wise)
Table 14.28 Manufacturing Execution System Companies: Distribution by Location of Headquarters (Country-wise)
Table 14.29 Manufacturing Execution System Companies: Distribution by Type of Company
Table 14.30 Manufacturing Execution System Companies: Distribution by Number of Platforms Offered
Table 14.31 Manufacturing Execution System Companies: Distribution by Deployment Options
Table 14.32 Manufacturing Execution Systems: Distribution by Platform Capabilities
Table 14.33 Manufacturing Execution Systems: Distribution by Integrating Software
Table 14.34 Manufacturing Execution Systems: Distribution by Types of Service(s) Offered
Table 14.35 Digital Twin Companies: Distribution by Year of Establishment
Table 14.36 Digital Twin Companies: Distribution by Company Size
Table 14.37 Digital Twin Companies: Distribution by Location of Headquarters (Region-wise)
Table 14.38 Digital Twin Companies: Distribution by Location of Headquarters (Country- wise)
Table 14.39 Digital Twin Companies: Distribution by Number of Platforms Offered
Table 14.40 Digital Twins Technologies: Distribution by Area(s) of Application
Table 14.41 Digital Twin Companies: Distribution by Type of End User(s)
Table 14.42 AspenTech: Annual Revenues, FY 2020-3M 2023 (USD Million)
Table 14.43 FUJIFILM Diosynth Biotechnologies: Annual Revenues, FY 2018-H1 2022 (USD Million)
Table 14.44 Merck: Annual Revenues, FY 2018-9M 2022 (USD Billion)
Table 14.45 Thermo Fisher Scientific: Annual Revenues, FY 2017-FY 2022 (USD Billion)
Table 14.46 Sartorius: Annual Revenues, FY 2017-FY 2022 (USD Million)
Table 14.47 Dassault Systèmes: Annual Revenues, FY 2017-FY 2021 (USD Billion)
Table 14.48 Körber: Annual Revenues, FY 2019-FY 2021 (USD Million)
Table 14.49 Benchmark Analysis: Distribution by Company Size and Region
Table 14.50 Partnerships and Collaborations: Distribution by Year of Partnership
Table 14.51 Partnerships and Collaborations: Distribution by Type of Partnership
Table 14.52 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 14.53 Partnerships and Collaborations: Distribution by Type of Technology
Table 14.54 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Technology
Table 14.55 Most Active Players: Distribution by Number of Partnerships
Table 14.56 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Table 14.57 Partnerships and Collaborations: International and Local Agreements
Table 14.58 Digital Biomanufacturing: Start-up Activity
Table 14.59 Global Digital Manufacturing Market for Biologics, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.60 Digital Manufacturing Market for Biologics: Distribution by Type of Technology, 2023 and 2035
Table 14.61 Process Analytical Technology Market for Biologic Manufacturing, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.62 Data Analysis Software Market for Biologic Manufacturing, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.63 Manufacturing Execution System Market for Biologic Manufacturing, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.64 Digital Twin Market for Biologic Manufacturing, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.65 Digital Manufacturing Market for Biologic: Distribution by Type of Deployment Options, 2023 and 2035
Table 14.66 Digital Biomanufacturing Market for Cloud-based Deployment Options, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.67 Digital Biomanufacturing Market for On-premises Deployment Options, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.68 Digital Manufacturing Market for Biologic: Distribution by Type(s) of Biologic(s) Manufactured, 2023 and 2035
Table 14.69 Digital Manufacturing Market for Antibodies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.70 Digital Manufacturing Market for Cell and Gene Therapies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.71 Digital Manufacturing Market for Proteins, Conservative, Base and OptimisticScenario, 2023-2035 (USD Million)
Table 14.72 Digital Manufacturing Market for Vaccines, Conservative, Base and OptimisticScenario, 2023-2035 (USD Million)
Table 14.73 Digital Manufacturing Market for Others, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.74 Digital Manufacturing Market for Biologics: Distribution by Geography, 2023 and 2035
Table 14.75 Digital Manufacturing Market in North America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.76 Digital Manufacturing Market in Europe, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.77 Digital Manufacturing Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.78 Digital Manufacturing Market in Latin America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.79 Digital Manufacturing Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. 908 Devices
  2. Sciex
  3. ABB
  4. Advanced Instruments
  5. Aegis Software
  6. Aggity
  7. Agilent Technologies
  8. Agilitech
  9. Aizon
  10. Ajinomoto
  11. Akron Biotech
  12. Alit Life Science
  13. Amazon Web Services
  14. Amgen
  15. Andrew Alliance
  16. APC
  17. Applied Materials
  18. Apprentice
  19. Arranta Bio
  20. Asimov
  21. AspenTech
  22. Atachi Systems
  23. Atos
  24. Automated Engineering Services (AES)
  25. Avantor
  26. AVEVA
  27. AX for Pharma
  28. BASE
  29. Beckman Coulter
  30. Benchling
  31. Bigfinite
  32. Bioengineering
  33. Biofactory Competence Centre
  34. Biofors Global
  35. BioIntelligence Technologies
  36. Bionet
  37. BioNTech
  38. BioPharm
  39. Bioprocess Technology
  40. Bioreactors.net
  41. BiOZEEN
  42. Birlasoft
  43. Bluecrux
  44. BlueSens
  45. Boan Biotech
  46. Bota Biosciences
  47. Caffeinated Capital
  48. CanCell Therapeutics
  49. Catapult Ventures
  50. CellPort
  51. Centre for Process Innovation
  52. COPA DATA
  53. CPI
  54. Creonis
  55. Cultivian Sandbox Ventures
  56. Culture Biosciences
  57. Cytiva
  58. CytomX Therapeutics
  59. Danyel Biotech
  60. Daspool
  61. Dassault Systèmes
  62. DataHow
  63. Diamyd Medical
  64. DRS Daylight Solutions
  65. Dutch State Mines (DSM)
  66. Emerson
  67. Encoded Therapeutics
  68. Enlight Technology
  69. Eppendorf
  70. Exyte
  71. FASTEC 
  72. Ferring Pharmaceuticals
  73. Flownamics
  74. Fluxa
  75. FUJIFILM Diosynth Biotechnologies
  76. Ganymede Bio
  77. GE Healthcare
  78. Gemma Frisius
  79. Genedata
  80. GenSensor
  81. GoSilico 
  82. Gramener
  83. Gritstone Oncology
  84. Hamilton
  85. Hexagon
  86. Honeywell
  87. Icosagen
  88. IDBS
  89. ILS Automation
  90. Infors
  91. Infoteam Automation
  92. inmation Software
  93. Insilico Biotechnology
  94. Integra CMS
  95. Integrix Solutions
  96. Inventrax 
  97. Körber
  98. Kuhner
  99. KYDEA
  100. KYNOTA
  101. Laurus Infosystems
  102. Leanios
  103. Light Chain Bioscience
  104. LRM
  105. LZ Lifescience
  106. MastersControl
  107. Merck
  108. MERSEN
  109. Metronik
  110. Microbial Bioprocess Lab (MiBioLab)
  111. Microsaic Systems
  112. Microsoft
  113. MiNK Therapeutics
  114. MPDV
  115. MyCellHub
  116. Naobios
  117. National Physical Laboratory
  118. North Carolina State University
  119. Northpond Ventures
  120. Noshaq
  121. Novasign
  122. Octapharma
  123. Optimal Industrial Automation
  124. Orion Pharma
  125. OSPIN
  126. Overwatch Research
  127. Ovizio
  128. OVO Biomanufacturing
  129. Pall Corporation
  130. PendoTECH
  131. Perceptive Engineering
  132. PerkinElmer
  133. Pierre Guérin
  134. POMS
  135. PTC
  136. Purdue University
  137. QM Consulting
  138. Qubicon
  139. Repligen
  140. RESOLUTION Spectra Systems
  141. Rockwell Automation
  142. RoosterBio
  143. Sapio Sciences
  144. Sartorius
  145. Scientific Bioprocessing
  146. SCIEX
  147. Scispot.io
  148. Section 32
  149. Securecell
  150. Sensum
  151. Sequence
  152. Sequoia Capital China
  153. Shimadzu
  154. Siemens
  155. Skyland Analytics
  156. Smart Pharma Soft Solutions
  157. Solaris Biotechnology
  158. StreamNative
  159. Synthace
  160. TetraScience
  161. Teva Pharmaceuticals
  162. The CoFoundry
  163. The Faktory Fund
  164. Thermo Fisher Scientific
  165. Transcenta
  166. Trunovate
  167. Tulip
  168. ValitaCell
  169. Vimachem
  170. Vineti
  171. WisdomEngine
  172. Wyoming
  173. Xenomics
  174. Yokogawa Insilico Biotechnology
  175. Zenith Technologies
  176. ZETA

Source 1: https://bioprocessintl.com/manufacturing/information-technology/the-era-of-digital-biomanufacturing/
Source 2: https://www.nature.com/articles/s41587-022-01630-6

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com